HLA-E
is a | gene |
is | mentioned by |
Full name | major histocompatibility complex, class I, E |
EntrezGene | 3133 |
PheGenI | 3133 |
VariationViewer | 3133 |
ClinVar | HLA-E |
GeneCards | HLA-E |
dbSNP | 3133 |
Diseases | HLA-E |
SADR | 3133 |
HugeNav | 3133 |
wikipedia | HLA-E |
HLA-E | |
gopubmed | HLA-E |
EVS | HLA-E |
HEFalMp | HLA-E |
MyGene2 | HLA-E |
23andMe | HLA-E |
UniProt | P13747 |
Ensembl | ENSG00000204592 |
OMIM | 143010 |
# SNPs | 3 |
Max Magnitude | Chromosome position | Summary | |
---|---|---|---|
rs1059510 | 0 | 30,489,955 | |
rs1264457 | 0 | 30,490,287 | |
rs1264459 | 0 | 30,488,143 |
HLA-E is gene for a non-classical HLA antigen, with 2 functional variants. It has been connected to multiple cancer prognoses.
HLA-E*0103X is associated with susceptibility to Pemphigus vulgaris and Behcet's disease. E *0101/*0103X is associated with childhood onset diabetes[PMID 23362868]
HLA-E*0101 was associated with hepatitis C clearance in HIV patients with interaction of rs8099917. [PMID 23811951]
HLA-E O1:01 and HLA-E 01:03 have been connected to psoriasis, dependent on HLA-C.[PMID 24279916]
HLA-E genotype was associated with CMV infection after bone marrow transplant [PMID 23998599].
HLA-E*0103/0103 may be protective in allogeneic hematopoietic stem cell transplant [PMID 23395341].